X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3) 3
cell line, tumor (3) 3
cell proliferation - drug effects (3) 3
female (3) 3
humans (3) 3
index medicus (3) 3
oncology (3) 3
aneuploidy (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis (2) 2
breast cancer (2) 2
breast neoplasms - pathology (2) 2
cancer (2) 2
cancer therapies (2) 2
cell cycle (2) 2
cell survival - drug effects (2) 2
chemotherapy (2) 2
chromosomal instability (2) 2
genomic instability (2) 2
mice (2) 2
mice, scid (2) 2
proteins (2) 2
research (2) 2
tumors (2) 2
xenograft model antitumor assays (2) 2
activation (1) 1
anaphase (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibody (1) 1
antineoplastic agents - administration & dosage (1) 1
antitumor efficacy (1) 1
apoptosis - drug effects (1) 1
benzamides - pharmacology (1) 1
bioindicators (1) 1
biomarkers (1) 1
body weight (1) 1
body weight loss (1) 1
bone marrow (1) 1
bone marrow cells - cytology (1) 1
bone marrow cells - drug effects (1) 1
bone marrow cells - metabolism (1) 1
bone-marrow (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - metabolism (1) 1
breast-cancer (1) 1
cancer stem cell (1) 1
catalysis (1) 1
catalytic activity (1) 1
cdk4/6 inhibition (1) 1
cell cycle proteins - antagonists & inhibitors (1) 1
cell cycle proteins - genetics (1) 1
cell cycle proteins - metabolism (1) 1
cell division (1) 1
checkpoint (1) 1
chromosomal proteins, non-histone - genetics (1) 1
chromosomal proteins, non-histone - metabolism (1) 1
chromosomes (1) 1
cyclin-dependent kinase (1) 1
cyclin-dependent kinase 4 (1) 1
cyclin-dependent kinase 4 - antagonists & inhibitors (1) 1
cyclin-dependent kinase 4 - metabolism (1) 1
cyclin-dependent kinase 6 - antagonists & inhibitors (1) 1
cyclin-dependent kinase 6 - metabolism (1) 1
cytotoxicity (1) 1
discovery (1) 1
docetaxel (1) 1
drug synergism (1) 1
drug therapy (1) 1
evolution (1) 1
g1 phase cell cycle checkpoints - drug effects (1) 1
gene expression (1) 1
genetic aspects (1) 1
glycine - analogs & derivatives (1) 1
glycine - pharmacology (1) 1
growth (1) 1
hematology, oncology and palliative medicine (1) 1
histones - metabolism (1) 1
hypotheses (1) 1
inhibition (1) 1
inhibitors (1) 1
intestine, small - pathology (1) 1
kaplan-meier estimate (1) 1
kinases (1) 1
kinetochores (1) 1
mechanisms (1) 1
medicine (1) 1
metaphase (1) 1
metastasis (1) 1
mice, nude (1) 1
microtubules (1) 1
mitosis (1) 1
mitosis - drug effects (1) 1
monoclonal antibodies (1) 1
motor (1) 1
multidisciplinary sciences (1) 1
neoplasms, basal cell - drug therapy (1) 1
neoplasms, basal cell - metabolism (1) 1
neoplasms, basal cell - mortality (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 2012, Volume 328, Issue 2, pp. 261 - 270
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0138616 - e0138616
Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is... 
BREAST-CANCER | ANEUPLOIDY | KINETOCHORES | EVOLUTION | MICROTUBULES | MULTIDISCIPLINARY SCIENCES | CDK4/6 INHIBITION | MECHANISMS | DISCOVERY | SPINDLE-ASSEMBLY CHECKPOINT | CHROMOSOMAL INSTABILITY | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Phosphorylation | Intestine, Small - pathology | Apoptosis - drug effects | Protein-Tyrosine Kinases - metabolism | Humans | Transplantation, Heterologous | Cell Cycle Proteins - antagonists & inhibitors | Protein-Tyrosine Kinases - genetics | RNA Interference | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Bone Marrow Cells - drug effects | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Protein-Serine-Threonine Kinases - metabolism | Cell Survival - drug effects | Bone Marrow Cells - cytology | Cell Cycle Proteins - metabolism | Protein-Serine-Threonine Kinases - genetics | Rats | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Mice, SCID | Breast Neoplasms - drug therapy | Piperazines - pharmacology | Animals | Mitosis - drug effects | Breast Neoplasms - pathology | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Protein Kinase Inhibitors - toxicity | Breast Neoplasms - diagnosis | Cell Proliferation - drug effects | Mice | Pyridines - pharmacology | Histones - metabolism | G1 Phase Cell Cycle Checkpoints - drug effects | Bone Marrow Cells - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | RNA, Small Interfering - metabolism | Physiological aspects | Genetic aspects | Research | Mitosis | Protein kinases | Toxicity | Body weight | Cytotoxicity | Oncology | Body weight loss | Catalytic activity | Kinases | Cancer therapies | Cyclin-dependent kinase 4 | Genomic instability | Proteins | Cyclin-dependent kinase | Metaphase | Cell cycle | Bone marrow | Physiology | Bioindicators | Inhibition | Pretreatment | Catalysis | Drug therapy | Product safety | Chromosomes | Pharmaceutical sciences | Neutropenia | Stability | Research & development--R&D | Tumor cells | Cell division | Breast cancer | Pharmacology | Hypotheses | Inhibitors | Biomarkers | Safety research | Viability | Anaphase | Apoptosis | Tumors | Cancer | Index Medicus | Research & development | R&D
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 8 Supplement, pp. 1604 - 1604
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.